Abstract
Significant findings have been obtained on the relationship between
underlying cardiovascular disease and the severity of COVID-19 infection. Using
plasma profiles of patients with COVID-19, biomarkers in circulation were also
identified that varied depending on the patient's characteristics and disease. The
purpose of this study is to review the sources that focus on circulating biomarkers of
cardiopulmonary disorders. In addition to conventional biomarkers such as troponin,
we consider data from new emerging biomarkers about their roles in the prognosis of
severity, mortality in the hospital and effectiveness of treatment. Consideration of
mechanisms associated with circulating biomarkers in various conditions associated
with COVID-19 can provide broader tools for the diagnosis, treatment, and prognosis
of at-risk patients
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Recent Advances in Anti-Infective Drug Discovery
Recent Patents on Anti-Infective Drug Discovery
Current Metabolomics and Systems Biology (Discontinued)
Recent Advances in Inflammation & Allergy Drug Discovery
Current HIV Research
Anti-Infective Agents
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents